283 related articles for article (PubMed ID: 15841173)
1. Altered regulation of IL-2 production in systemic lupus erythematosus: an evolving paradigm.
Kammer GM
J Clin Invest; 2005 Apr; 115(4):836-40. PubMed ID: 15841173
[TBL] [Abstract][Full Text] [Related]
2. Reconstitution of deficient T cell receptor zeta chain restores T cell signaling and augments T cell receptor/CD3-induced interleukin-2 production in patients with systemic lupus erythematosus.
Nambiar MP; Fisher CU; Warke VG; Krishnan S; Mitchell JP; Delaney N; Tsokos GC
Arthritis Rheum; 2003 Jul; 48(7):1948-55. PubMed ID: 12847689
[TBL] [Abstract][Full Text] [Related]
3. Altered signal transduction in SLE T cells.
Tenbrock K; Juang YT; Kyttaris VC; Tsokos GC
Rheumatology (Oxford); 2007 Oct; 46(10):1525-30. PubMed ID: 17586862
[TBL] [Abstract][Full Text] [Related]
4. Attempt to correct abnormal signal transduction in T lymphocytes from systemic lupus erythematosus patients.
Fujii Y; Fujii K; Tanaka Y
Autoimmun Rev; 2006 Feb; 5(2):143-4. PubMed ID: 16431347
[TBL] [Abstract][Full Text] [Related]
5. Systemic lupus erythematosus serum IgG increases CREM binding to the IL-2 promoter and suppresses IL-2 production through CaMKIV.
Juang YT; Wang Y; Solomou EE; Li Y; Mawrin C; Tenbrock K; Kyttaris VC; Tsokos GC
J Clin Invest; 2005 Apr; 115(4):996-1005. PubMed ID: 15841182
[TBL] [Abstract][Full Text] [Related]
6. TCR/CD3 complex-mediated signal transduction pathway in T cells and T cell lines from patients with systemic lupus erythematosus.
Vassilopoulos D; Kovacs B; Tsokos GC
J Immunol; 1995 Aug; 155(4):2269-81. PubMed ID: 7636273
[TBL] [Abstract][Full Text] [Related]
7. T-cell signaling abnormalities in human systemic lupus erythematosus.
Nambiar MP; Krishnan S; Tsokos GC
Methods Mol Med; 2004; 102():31-47. PubMed ID: 15286379
[TBL] [Abstract][Full Text] [Related]
8. Altered expression of the T cell receptor-CD3 complex in systemic lupus erythematosus.
Takeuchi T; Tsuzaka K; Abe T
Int Rev Immunol; 2004; 23(3-4):273-91. PubMed ID: 15204089
[TBL] [Abstract][Full Text] [Related]
9. Phorbol myristate acetate (PMA) reverses inhibition of interleukin-2 production by T lymphocytes of patients with systemic lupus erythematosus.
Sierakowski S; Kucharz EJ
Med Interne; 1988; 26(1):67-73. PubMed ID: 3261032
[TBL] [Abstract][Full Text] [Related]
10. Lithium in vitro enhances interleukin-2 production by T cells from patients with systemic lupus erythematosus.
Kucharz EJ; Sierakowski SJ; Goodwin JS
Immunopharmacol Immunotoxicol; 1993 Nov; 15(5):515-23. PubMed ID: 8301016
[TBL] [Abstract][Full Text] [Related]
11. Expression and function of inducible co-stimulator in patients with systemic lupus erythematosus: possible involvement in excessive interferon-gamma and anti-double-stranded DNA antibody production.
Kawamoto M; Harigai M; Hara M; Kawaguchi Y; Tezuka K; Tanaka M; Sugiura T; Katsumata Y; Fukasawa C; Ichida H; Higami S; Kamatani N
Arthritis Res Ther; 2006; 8(3):R62. PubMed ID: 16563187
[TBL] [Abstract][Full Text] [Related]
12. Transcriptional regulation of interleukin 2 in SLE T cells.
Tenbrock K; Tsokos GC
Int Rev Immunol; 2004; 23(3-4):333-45. PubMed ID: 15204092
[TBL] [Abstract][Full Text] [Related]
13. [Abnormal signaling activity of phosphatidylinositol 3-kinase pathway in peripheral blood T cells from patients with systemic lupus erythematosus].
Liang LQ; Zhan ZP; Xu HS; Yang XY; Ye YJ; Lian F; Qiu Q
Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(29):2036-40. PubMed ID: 19080430
[TBL] [Abstract][Full Text] [Related]
14. Functional properties of CD8 positive lymphocyte subsets in systemic lupus erythematosus.
Horwitz DA; Linker-Israeli M; Gray JD; Lemoine C
J Rheumatol Suppl; 1987 Jun; 14 Suppl 13():49-52. PubMed ID: 2956420
[TBL] [Abstract][Full Text] [Related]
15. Constitutive expression of IL-6 receptors and their role in the excessive B cell function in patients with systemic lupus erythematosus.
Nagafuchi H; Suzuki N; Mizushima Y; Sakane T
J Immunol; 1993 Dec; 151(11):6525-34. PubMed ID: 8245483
[TBL] [Abstract][Full Text] [Related]
16. Altered signaling triggered by ligation of the TCR/CD3 receptor in T lymphocytes from patients with systemic lupus erythematosus: the road from anergy to autoimmunity.
Blasini AM; Rodríguez MA
Int Rev Immunol; 2004; 23(3-4):265-72. PubMed ID: 15204088
[TBL] [Abstract][Full Text] [Related]
17. Responsiveness of systemic lupus erythematosus T cells to signals provided through LCA T200 (CD45) and T1 (CD5) antigens.
Martorell J; Font J; Rojo I; Vilella R; Ingelmo M; Vives J
Clin Exp Immunol; 1989 Nov; 78(2):172-6. PubMed ID: 12412744
[TBL] [Abstract][Full Text] [Related]
18. Dissecting the molecular mechanisms of TCR zeta chain downregulation and T cell signaling abnormalities in human systemic lupus erythematosus.
Nambiar MP; Juang YT; Krishnan S; Tsokos GC
Int Rev Immunol; 2004; 23(3-4):245-63. PubMed ID: 15204087
[TBL] [Abstract][Full Text] [Related]
19. Interleukin 2 and systemic lupus erythematosus: beyond the transcriptional regulatory net abnormalities.
Gómez-Martín D; Díaz-Zamudio M; Crispín JC; Alcocer-Varela J
Autoimmun Rev; 2009 Sep; 9(1):34-9. PubMed ID: 19269352
[TBL] [Abstract][Full Text] [Related]
20. Identification of microRNA-31 as a novel regulator contributing to impaired interleukin-2 production in T cells from patients with systemic lupus erythematosus.
Fan W; Liang D; Tang Y; Qu B; Cui H; Luo X; Huang X; Chen S; Higgs BW; Jallal B; Yao Y; Harley JB; Shen N
Arthritis Rheum; 2012 Nov; 64(11):3715-25. PubMed ID: 22736314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
